Previously, administration of exogenous hCG and FSH has been classically found to effectively induce spermatogenesis for non-obstructive azoospermia in men with hypogonadotropic hypogonadism [11, 12]. The gene discussed is BRD2; the disease is hypogonadotropic hypogonadism.